Zhen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhen Zhang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Cao
CISRO Manufacturing Ian Wark Laboratory Melbourne 3168 Victoria (VIC Australia
1 shared publication - Brenda P. Williams
Basic and Clinical Neuroscience Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London
1 shared publication Chad Heazlewood
Commonwealth Scientific and Industrial Research Organization, Canberra, Australia
1 shared publication- Chen Li
Department of Breast Surgery, Peking University International Hospital, Beijing, China
1 shared publication - Chuqiao Sheng
Department of Pediatric Intensive Care Unit , Children’s Medical Center Changchun, Jilin 130021 , China
1 shared publication - Dong-Xin Wang
Peking University First Hospital
1 shared publication
Latest Publications
- Open Access
- 5 February 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , 212-220
Effects of Peripheral Nerve Block on Perioperative Recovery following Major Thoracic and Abdominal Surgery
Objective: To test the hypothesis that peripheral nerve block (PNB) use might be associated with improved perioperative outcomes after major surgery. Background: PNB has been used to improve postoperative analgesia. Methods: This was a retrospective cohort study with propensity score matching. We included patients aged ≥65 years who underwent major (≥2 hours) non-cardiac thoracic and abdominal surgery under general anesthesia. Data were analyzed according to whether patients received PNB or not during anesthesia. Our primary outcome was the length of hospital stay; secondary outcomes included occurrence of major complications in hospital after surgery. Results: A total of 1915 patients were included in the full cohort, of whom 1316 received PNB and 599 did not; 1174 patients remained in the cohort after matching, with 587 in each group. Length of hospital stay after surgery was shorter in patients who received PNB than in those who did not [7 days (5–9) with PNB vs 7 days (5–11) without PNB: hazard ratio: 1.15, 95% CI: 1.02–1.29, P = 0.012]. When compared with patients who did not receive PNB, those who received PNB developed fewer major complications during hospital stay (relative risk: 0.41, 95% CI: 0.30–0.58, P < 0.001). Patients with PNB required less supplemental analgesia within 72 h (relative risk: 0.70, 95% CI: 0.59–0.84, P < 0.001). Conclusions: The use of PNB was associated with shortened length of hospital stay and reduced major complications in older patients after major non-cardiac thoracic and abdominal surgery, possibly due to improved analgesia.
- 5 February 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , 212-220
Open AccessEffects of Peripheral Nerve Block on Perioperative Recovery following Major Thoracic and Abdominal Surgery
Objective: To test the hypothesis that peripheral nerve block (PNB) use might be associated with improved perioperative outcomes after major surgery. Background: PNB has been used to improve postoperative analgesia. Methods: This was a retrospective cohort study with propensity score matching. We included patients aged ≥65 years who underwent major (≥2 hours) non-cardiac thoracic and abdominal surgery under general anesthesia. Data were analyzed according to whether patients received PNB or not during anesthesia. Our primary outcome was the length of hospital stay; secondary outcomes included occurrence of major complications in hospital after surgery. Results: A total of 1915 patients were included in the full cohort, of whom 1316 received PNB and 599 did not; 1174 patients remained in the cohort after matching, with 587 in each group. Length of hospital stay after surgery was shorter in patients who received PNB than in those who did not [7 days (5–9) with PNB vs 7 days (5–11) without PNB: hazard ratio: 1.15, 95% CI: 1.02–1.29, P = 0.012]. When compared with patients who did not receive PNB, those who received PNB developed fewer major complications during hospital stay (relative risk: 0.41, 95% CI: 0.30–0.58, P < 0.001). Patients with PNB required less supplemental analgesia within 72 h (relative risk: 0.70, 95% CI: 0.59–0.84, P < 0.001). Conclusions: The use of PNB was associated with shortened length of hospital stay and reduced major complications in older patients after major non-cardiac thoracic and abdominal surgery, possibly due to improved analgesia.
- 26 September 2022
- Published by Elsevier in Journal of Luminescence
- Vol. 252, 119339
Revisiting the self-termination effect of erbium based near 3 μm mid-infrared lasers
- 26 September 2022
- Published by Elsevier in Journal of Luminescence
- Vol. 252, 119339
Revisiting the self-termination effect of erbium based near 3 μm mid-infrared lasers
- Open Access
- 6 April 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-10
Ultrasound-guided erector spinae plane block versus thoracic paravertebral block on postoperative analgesia after laparoscopic nephroureterectomy: study protocol of a randomized, double-blinded, non-inferiority design trial
Introduction: Erector spinae plane block (ESPB) is a novel inter-fascial plane block, which is applied more and more in postoperative pain control, especially in chest surgery. Regional block is advocated in order to decrease opioid consumption and improve analgesia in urological surgery. Therefore, we aimed to explore whether ESPB would have similar analgesia compared with thoracic paravertebral block (TPVB) in laparoscopic nephroureterectomy. Methods and analysis: This prospective, randomized, double-blinded, non-inferiority trial will enroll 166 patients undergoing laparoscopic nephroureterectomy. Participants will be randomly assigned 1:1 into receiving ESPB or TPVB before surgery. Both ultrasound-guided ESPB and TPVB will be performed with an injection of 0.375% ropivacaine 0.4 ml/kg before anesthesia induction. Standardized patients controlled intravenous analgesia (PCIA) will be applied for each patient. The primary endpoint is the joint of cumulative 24 h opioid (sufentanil) consumption and average pain score via numeric rating scale (NRS) at 24 h after surgery. Secondary endpoints include rescued analgesic demand, cumulative opioid consumption, and pain NRS scores at different preset timepoints within 48 h after surgery. Other predefined outcomes include clinical features of blockage, quality of recovery, subjective sleep quality, time to ambulation and diet, and adverse events, as well as length of stay in hospital and anesthesia cost. Discussion: Previous studies investigating the analgesic efficacy of ESPB only concentrated on a single endpoint for postoperative pain evaluation, while studies focusing on the direct comparison between ESPB and TPVB in urological surgery are still lacking. Our study is the first trial in non-inferiority design of comparing ESPB and TPVB in patient undergoing laparoscopic nephroureterectomy, and the primary outcome is the joint endpoint of opioid consumption and pain NRS score. Trial registration: Chinese Clinical Trial Registry ChiCTR 2000031916. Registered on 14 April 2020.
- 6 April 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-10
Open AccessUltrasound-guided erector spinae plane block versus thoracic paravertebral block on postoperative analgesia after laparoscopic nephroureterectomy: study protocol of a randomized, double-blinded, non-inferiority design trial
Introduction: Erector spinae plane block (ESPB) is a novel inter-fascial plane block, which is applied more and more in postoperative pain control, especially in chest surgery. Regional block is advocated in order to decrease opioid consumption and improve analgesia in urological surgery. Therefore, we aimed to explore whether ESPB would have similar analgesia compared with thoracic paravertebral block (TPVB) in laparoscopic nephroureterectomy. Methods and analysis: This prospective, randomized, double-blinded, non-inferiority trial will enroll 166 patients undergoing laparoscopic nephroureterectomy. Participants will be randomly assigned 1:1 into receiving ESPB or TPVB before surgery. Both ultrasound-guided ESPB and TPVB will be performed with an injection of 0.375% ropivacaine 0.4 ml/kg before anesthesia induction. Standardized patients controlled intravenous analgesia (PCIA) will be applied for each patient. The primary endpoint is the joint of cumulative 24 h opioid (sufentanil) consumption and average pain score via numeric rating scale (NRS) at 24 h after surgery. Secondary endpoints include rescued analgesic demand, cumulative opioid consumption, and pain NRS scores at different preset timepoints within 48 h after surgery. Other predefined outcomes include clinical features of blockage, quality of recovery, subjective sleep quality, time to ambulation and diet, and adverse events, as well as length of stay in hospital and anesthesia cost. Discussion: Previous studies investigating the analgesic efficacy of ESPB only concentrated on a single endpoint for postoperative pain evaluation, while studies focusing on the direct comparison between ESPB and TPVB in urological surgery are still lacking. Our study is the first trial in non-inferiority design of comparing ESPB and TPVB in patient undergoing laparoscopic nephroureterectomy, and the primary outcome is the joint endpoint of opioid consumption and pain NRS score. Trial registration: Chinese Clinical Trial Registry ChiCTR 2000031916. Registered on 14 April 2020.
- Open Access
- 1 October 2017
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 63 (10) , 904-909
Changes in serum cardiac myosin light chain 1 levels in children with fulminant myocarditis during continuous blood purification
Keywords: myocarditis; child; myosins/immunology/metabolism; hemofiltration
- 1 October 2017
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 63 (10) , 904-909
Open AccessChanges in serum cardiac myosin light chain 1 levels in children with fulminant myocarditis during continuous blood purification
Keywords: myocarditis; child; myosins/immunology/metabolism; hemofiltration
- 1 September 2016
- Published by Elsevier in Experimental Hematology
- Vol. 44 (9) , S53-S54
Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist
- 1 September 2016
- Published by Elsevier in Experimental Hematology
- Vol. 44 (9) , S53-S54
Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist
- 15 March 2014
- Published by China Journal of Chinese Materia Medica in China Journal of Chinese Materia Medica
- Vol. 39 (6) , 1058-63
Effect of paeonol on adhesive function of rat vascular endothelial cells induced by lipopolysaccharide and co-cultured with smooth muscle cells
To observe the changes in the adhesive function of vascular endothelial cells (VEC) and rat monocytes induced by lipopolysaccharide (LPS) and co-cultured with smooth muscle cells (SMC) and the intervention effect of paeonol (Pae). Primary rat vascular endothelial cells (VECs) and rat vascular smooth muscle cells (VSMCs) were cultured by predigesting and adhering tissue blocks. The VEC-VSMC co-culture model was established by Transwell chamber. LPS was used to induce VEC injury. MTT assay and LDH assay were used to determine the VEC activity. ELISA assay was used to detect IL-1beta and TNF-alpha secreted by the VEC. The immunocytochemistry assay was carried out to detect the expression of ICAM-1. The Rose Bengal Staining was used to test adhesive function between VECs and monocytes. The concentration of LPS-induced VEC injury was 100 microg x L(-1), and the time was 7 h. after the intervention on the above cell model for 24 h, Paeonol (15, 30, 60 micromol x L(-1)) could effectively inhibit LPS-induced VEC injury and VEC injury, significantly enhance the survival rate of LPS-injured VECs, decrease IL-1beta and TNF-alpha secreted by the injured VEC, and reduce the expression of ICAM-1, so as to inhibit the adhesion of LPS-induced VECs and monocytes. Paeonol could inhibit IL-1beta and TNF-alpha expression to protect VECs from being injured by LPS, and reduce ICAM-1 expression to inhibit the adhesion between VECs and monocytes.
- 15 March 2014
- Published by China Journal of Chinese Materia Medica in China Journal of Chinese Materia Medica
- Vol. 39 (6) , 1058-63
Effect of paeonol on adhesive function of rat vascular endothelial cells induced by lipopolysaccharide and co-cultured with smooth muscle cells
To observe the changes in the adhesive function of vascular endothelial cells (VEC) and rat monocytes induced by lipopolysaccharide (LPS) and co-cultured with smooth muscle cells (SMC) and the intervention effect of paeonol (Pae). Primary rat vascular endothelial cells (VECs) and rat vascular smooth muscle cells (VSMCs) were cultured by predigesting and adhering tissue blocks. The VEC-VSMC co-culture model was established by Transwell chamber. LPS was used to induce VEC injury. MTT assay and LDH assay were used to determine the VEC activity. ELISA assay was used to detect IL-1beta and TNF-alpha secreted by the VEC. The immunocytochemistry assay was carried out to detect the expression of ICAM-1. The Rose Bengal Staining was used to test adhesive function between VECs and monocytes. The concentration of LPS-induced VEC injury was 100 microg x L(-1), and the time was 7 h. after the intervention on the above cell model for 24 h, Paeonol (15, 30, 60 micromol x L(-1)) could effectively inhibit LPS-induced VEC injury and VEC injury, significantly enhance the survival rate of LPS-injured VECs, decrease IL-1beta and TNF-alpha secreted by the injured VEC, and reduce the expression of ICAM-1, so as to inhibit the adhesion of LPS-induced VECs and monocytes. Paeonol could inhibit IL-1beta and TNF-alpha expression to protect VECs from being injured by LPS, and reduce ICAM-1 expression to inhibit the adhesion between VECs and monocytes.